PUBLISHER: The Business Research Company | PRODUCT CODE: 1942831
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942831
Erectile dysfunction devices are medical instruments intended to assist individuals with erectile dysfunction (ED) in achieving and sustaining an erection adequate for sexual activity. These devices utilize various methods, including suction, constriction, or medication delivery, to enhance blood flow to the penis or support its firmness.
There are two primary types of erectile dysfunction devices non-surgical and surgical. Non-surgical devices are designed to help men achieve and maintain an erection without the need for surgery. They are used to address conditions such as diabetes, neurological disorders, and hypertension, and can be either invasive or non-invasive. These devices cater to different age groups-under 40 years, 40-60 years, and over 60 years-and are utilized by various end-users including hospitals, clinics, ambulatory surgical centers, and others.
Tariffs are impacting the erectile dysfunction devices market by increasing costs for imported medical-grade materials, mechanical components, and precision-manufactured implant parts. These impacts are most pronounced across surgical devices and advanced non-surgical systems, particularly in regions dependent on international manufacturing such as asia-pacific and europe. Higher device costs have influenced pricing and reimbursement dynamics in hospitals and specialty clinics. At the same time, tariffs are encouraging local manufacturing, supplier diversification, and cost-efficient device design, creating long-term opportunities for regional players.
The erectile dysfunction devices market research report is one of a series of new reports from The Business Research Company that provides erectile dysfunction devices market statistics, including erectile dysfunction devices industry global market size, regional shares, competitors with a erectile dysfunction devices market share, detailed erectile dysfunction devices market segments, market trends and opportunities, and any further data you may need to thrive in the erectile dysfunction devices industry. This erectile dysfunction devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The erectile dysfunction devices market size has grown rapidly in recent years. It will grow from $2.09 billion in 2025 to $2.35 billion in 2026 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to rising prevalence of diabetes, increasing incidence of cardiovascular diseases, growing aging male population, increased awareness of erectile dysfunction treatments, expanding availability of urology care services.
The erectile dysfunction devices market size is expected to see rapid growth in the next few years. It will grow to $3.73 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to rising prevalence of lifestyle-related disorders, growing male health awareness, increasing acceptance of medical devices for sexual health, expanding access to minimally invasive treatments, improving healthcare infrastructure in emerging markets. Major trends in the forecast period include rising adoption of non-invasive erectile dysfunction devices, growing preference for at-home erectile dysfunction management, increasing demand for vacuum erection and penile pump devices, rising acceptance of surgical penile implants in severe ed cases, growing focus on personalized erectile dysfunction treatment.
The rising prevalence of prostate cancer is expected to drive the growth of the erectile dysfunction devices market. Prostate cancer, originating in the prostate gland-a small organ below the bladder responsible for producing part of semen-affects a significant number of men. The increase in prostate cancer cases is linked to aging populations, better detection methods, and lifestyle factors that may influence the disease's prevalence. Erectile dysfunction devices are crucial for prostate cancer patients, as they help restore sexual function and enhance quality of life after treatment, which can often affect erectile capabilities. For instance, in September 2025, according to the American Cancer Society, a US-based professional organization, approximately 313,780 new cases of prostate cancer are expected in the United States in 2025. The risk of developing prostate cancer increases significantly with age, rising from 0.2% in men under 50 to 6.5% in those aged 70-79. Hence, the increasing prevalence of prostate cancer is fueling the growth of the erectile dysfunction devices market.
Leading companies in the erectile dysfunction devices market are focusing on developing advanced, non-invasive products to gain a competitive edge. Non-invasive erectile dysfunction devices are medical tools designed to improve or restore erectile function without surgical intervention, often using methods such as vacuum therapy, electrical stimulation, or non-penetrative penile implants. For example, in June 2024, Ohh Med Medical, an Israel-based medical equipment manufacturer, introduced the VerticaPlus device for erectile dysfunction. This innovative device includes a cloud-based mobile app that enhances the therapy experience with real-time feedback and quality tracking. The upgraded version features the app as a personal coach, offering ongoing feedback, step-by-step tutorials, and customized settings for more effective therapy.
In May 2025, Shanghai Taiyuan Life Science, a China-based biotechnology company, partnered with Initia Ltd. to advance next-generation biologic solutions in life sciences. The collaboration aims to expand access to, and distribution of, high-quality biologic products, improving patient outcomes while driving innovation and growth in the biologics market. Initia Ltd. is a UK-based biotechnology company specializing in the commercialization of advanced biologics for therapeutic applications.
Major companies operating in the erectile dysfunction devices market are Boston Scientific Corporation, Coloplast Corporation, MTS Medical AG, Alma Lasers Ltd., Shenzhen Huikang Medical Apparatus Co Ltd, Storz Medical AG, UroMatrix Medical Systems, Medispec Ltd., Zephyr Surgical Implants, Timm Medical Technologies Inc., Promedon GmbH, Zimmer MedizinSysteme GmbH, Rigicon Inc., NOVAmedtek, Vacurect, The Elator, Silimed Industria de Implantes, Restore Medical Inc, Medtronic plc, Titan Medical Inc, Encore Medical Ltd
North America was the largest region in the erectile dysfunction devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the erectile dysfunction devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the erectile dysfunction devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The erectile dysfunction devices market consists of sales of penile prostheses, injection therapy devices, urethral suppositories, and related products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Erectile Dysfunction Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses erectile dysfunction devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for erectile dysfunction devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The erectile dysfunction devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.